Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,149
+$738 QoQ
Shares Held
186
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,471
of 1,603 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $12,175,651 across 14 Drug Manufacturers - General names. NVS ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,170 | $9,694,033 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,609 | $1,106,256 | |
| 3 | LLY |
ELI LILLY & Co
|
530 | $635,697 | |
| 4 | PFE |
Pfizer Inc
|
14,289 | $344,079 | |
| 5 | ABBV |
AbbVie Inc.
|
522 | $131,356 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,010 | $115,816 | |
| 7 | GSK |
GSK plc
|
1,381 | $72,392 | |
| 8 | NVS |
Novartis AG
This page
|
186 | $29,149 |
All Filings in NVS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,149 | 186 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $28,411 | 186 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $28,401 | 206 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $21,800 | 170 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $20,571 | 170 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,951 | 170 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,596 | 150 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $17,253 | 150 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $15,969 | 150 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $14,509 | 150 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $15,145 | 150 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $15,279 | 150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,136 | 150 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $13,800 | 150 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $13,608 | 150 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,800 | 50 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $4,226 | 50 | Shares | Sole | 2022-09-21 | |
| No filing history on record for this holder in this stock. | ||||||